Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 334, pseudogene (RN7SL334P)** is a member of the pseudogenes derived from the 7SL RNA gene family, which encodes the RNA component of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum[7][6][2]. Pseudogenes like RN7SL334P are truncated, non-functional copies that arise when RNA intermediates are reverse-transcribed and integrated back into the genome[7]. Unlike functional 7SL RNA, which plays a central role in protein targeting as part of the SRP complex, **RN7SL334P is not known to have a biological function and is not an active therapeutic target**[7][2]. Pseudogenes from this family are widely dispersed in the human genome, and while the canonical 7SL RNA gene has implications in processes like protein synthesis and potentially in cancer, the pseudogenes themselves are mainly regarded as genomic remnants without known direct functional or disease roles[7][5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 334, pseudogene (RN7SL334P).